Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alnylam
Pharma
Moderna, Alnylam resolve COVID-19 vaccine patent litigation
The lawsuits were part of the large web of COVID-19 vaccine patent infringement cases filed against—and by—the most prominent vaccine makers.
Eric Sagonowsky
Sep 19, 2025 9:40am
Alnylam's market cap jumps past $50B
Aug 1, 2025 7:39am
Alnylam's Amvuttra off to promising start in ATTR-CM
May 1, 2025 11:46am
Sanofi scores FDA nod for Qfitlia for all types of hemophilia
Mar 28, 2025 3:21pm
Alnylam's Amvuttra wins key cardiomyopathy FDA nod
Mar 20, 2025 7:40pm
Pfizer's ATTR drug again faces pricing scrutiny
Oct 21, 2024 2:55pm
